Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Palette Life Sciences Inc. has 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. The portfolio is split between 2 distinct examiners and 2 distinct art units, which requires navigating different examination styles. ROZANSKI, MICHAEL T is the busiest examiner for the company with 1 pending action.
Because the 2 actions are spread across 2 art units, the company faces a diverse set of technical reviews. This spread suggests that prosecution strategies may need to be tailored to the specific nuances of the 2 examiners involved. Maintaining consistency across these separate administrative units is essential for a unified patent strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROZANSKI, MICHAEL T | 1 | 69.1% | +29.0% |
| MEJIAS, SAMANTHA LEE | 1 | 41.2% | +31.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18799913 | TISSUE SPACERS WITH VISUAL ADDITIVE | ROZANSKI, MICHAEL T | — |
| 17522674 | TISSUE SPACERS | MEJIAS, SAMANTHA LEE | — |
| Art Unit | Apps |
|---|---|
| 3797 | 1 |
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18799913 | TISSUE SPACERS WITH VISUAL ADDITIVE | ROZANSKI, MICHAEL T | 3797 | §103DP | Non-Final OA | — | Pending | Aug 09, 2024 |
| 17522674 | TISSUE SPACERS | MEJIAS, SAMANTHA LEE | 1618 | §103 | Non-Final OA | — | Pending | Nov 09, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPalette Life Sciences Inc. has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Michael T Rozanski has the most, with 1 of Palette Life Sciences Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.